Detailed answers about OPSIS AESTHETIC MEDICAL CONSULTANTS LIMITED, including incorporation, status, business activity, and accounts information.
When was OPSIS AESTHETIC MEDICAL CONSULTANTS LIMITED founded?
OPSIS AESTHETIC MEDICAL CONSULTANTS LIMITED was officially incorporated on 23 November 2006 and is registered under company number 06007772. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is OPSIS AESTHETIC MEDICAL CONSULTANTS LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of OPSIS AESTHETIC MEDICAL CONSULTANTS LIMITED?
OPSIS AESTHETIC MEDICAL CONSULTANTS LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does OPSIS AESTHETIC MEDICAL CONSULTANTS LIMITED do?
OPSIS AESTHETIC MEDICAL CONSULTANTS LIMITED operates in the following sector: 74909 - Other professional, scientific and technical activities n.e.c.. This provides insight into the company's primary business activity and industry focus.
What is OPSIS AESTHETIC MEDICAL CONSULTANTS LIMITED's registered address?
The registered office address of OPSIS AESTHETIC MEDICAL CONSULTANTS LIMITED is DORAN, SOUTHGATE ROAD, POTTERS BAR, HERTFORDSHIRE, ENGLAND, EN6 5EH. This is the official address filed with Companies House for legal and statutory correspondence.
Is OPSIS AESTHETIC MEDICAL CONSULTANTS LIMITED financially stable?
The most recent accounts for OPSIS AESTHETIC MEDICAL CONSULTANTS LIMITED were made up to 31 March 2024, filed as MICRO ENTITY. Next accounts are due by 31 March 2026.